{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:54:53Z","timestamp":1789473293705,"version":"build-2803163510"},"reference-count":37,"publisher":"Baishideng Publishing Group Inc.","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2004]]},"DOI":"10.3748\/wjg.v10.i7.1047","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T05:32:18Z","timestamp":1509341538000},"page":"1047","source":"Crossref","is-referenced-by-count":40,"title":["Effects of PPARg agonist pioglitazone on rat hepatic fibrosis"],"prefix":"10.3748","volume":"10","author":[{"given":"Guang-Jin","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-Jiong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000071455"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00972-7"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, Caselmann WH. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001;7:208-215.","DOI":"10.3748\/wjg.v7.i2.208"},{"key":"ref4","unstructured":"Lee HS, Huang GT, Chen CH, Chiou LL, Lee CC, Yang PM, Chen DS, Sheu JC. Less reversal of liver fibrosis after prolonged carbon tetrachloride injection. Hepatogastroenterology 2001;48:1312-1315."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2000.020003191.x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.5.658"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.252"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/15209150050194297"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.5.815"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Lawrence JM, Reckless JP. Pioglitazone. Int J Clin Pract 2000;54:614-618.","DOI":"10.1111\/j.1742-1241.2000.tb10937.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2002.6385"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33666"},{"key":"ref13","unstructured":"Hepatic Fibrosis Study Group Of Chinese Liver Diseases Association. Consensus on evaluation of the diagnosis and efficacy of hepatic fibrosis. Zhonghua Ganzangbing Zazhi 2002;10:327-328."},{"key":"ref14","unstructured":"Safadi R, Friedman SL. Hepatic fibrosis--role of hepatic stellate cell activation. MedGenMed 2002;4:27."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Dai WJ, Jiang HC. Advances in gene therapy of liver cirrhosis: a review. World J Gastroenterol 2001;7:1-8.","DOI":"10.3748\/wjg.v7.i1.1"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Wei HS, Lu HM, Li DG, Zhan YT, Wang ZR, Huang X, Cheng JL, Xu QF. The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis: effects of RAS inhibitors on hepatic fibrosis induced by CCl(4). World J Gastroenterol 2000;6:824-828.","DOI":"10.3748\/wjg.v6.i6.824"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s005350070045"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M006577200"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310117"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.9365"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00474.2002"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Liu WB, Yang CQ, Jiang W, Wang YQ, Guo JS, He BM, Wang JY. Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid. World J Gastroenterol 2003;9:316-319.","DOI":"10.3748\/wjg.v9.i2.316"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Weng HL, Cai WM, Liu RH. Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis. World J Gastroenterol 2001;7:42-48.","DOI":"10.3748\/wjg.v7.i1.42"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Wang JY, Zhang QS, Guo JS, Hu MY. Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats. World J Gastroenterol 2001;7:115-119.","DOI":"10.3748\/wjg.v7.i1.115"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Geerts A, Lazou JM, De Bleser P, Wisse E. Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology 1991;13:1193-1202.","DOI":"10.1002\/hep.1840130628"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.1999.tb00038.x"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Zheng RQ, Wang QH, Lu MD, Xie SB, Ren J, Su ZZ, Cai YK, Yao JL. Liver fibrosis in chronic viral hepatitis: an ultrasonographic study. World J Gastroenterol 2003;9:2484-2489.","DOI":"10.3748\/wjg.v9.i11.2484"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1006\/exmp.2001.2399"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Rivera CA, Bradford BU, Hunt KJ, Adachi Y, Schrum LW, Koop DR, Burchardt ER, Rippe RA, Thurman RG. Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine. Am J Physiol Gastrointest Liver Physiol 2001;281:G200-G207.","DOI":"10.1152\/ajpgi.2001.281.1.G200"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/nri912"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2174\/1568010023344616"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v23.i12.10"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/34178"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/35154"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Bull AW. The role of peroxisome proliferator-activated receptor gamma in colon cancer and inflammatory bowel disease. Arch Pathol Lab Med 2003;127:1121-1123.","DOI":"10.5858\/2003-127-1121-TROPPR"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01946-5"},{"key":"ref37","unstructured":"Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, Fujita T. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneimittelforschung 1990;40:156-162."}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i7\/1047.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:54:23Z","timestamp":1750967663000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i7\/1047.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v10.i7.1047","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2004]]}}}